Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2372 (LINC02372)
- Target
- LINC02372
- Molecular classification
- Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA), intergenic subtype, RNA gene (non-protein coding)
01
Overview
Long intergenic non-protein coding RNA 2372 (LINC02372) is a human gene that encodes a long intergenic non-coding RNA (lincRNA), characterized by its location in regions of the genome that do not overlap with protein-coding genes. LincRNAs are defined as non-coding RNAs longer than 200 nucleotides and are known to participate in diverse gene regulatory functions including chromatin remodeling, transcriptional, and post-transcriptional regulation; however, the specific function of LINC02372 itself has not been elucidated or experimentally validated. There is currently no evidence linking LINC02372 specifically to disease, drug interactions, or use as a clinical biomarker. Most knowledge about lincRNAs, as a class, suggests they can play roles in fine-tuning gene expression and could be relevant in disease if further studied, but no such data is currently available for LINC02372.
- Other names
- LINC02372Long intergenic non-protein coding RNA 2372
02
Mechanism of action
None known (no drugs or therapies reported to act on LINC02372)
03
Biological functions
Regulation of gene expression (general property of lincRNAs, specific function for LINC02372 is not described in the literature)Chromatin remodeling/scaffolding (not LINC02372-specific, but common among lincRNAs)Potential fine-tuning of neighboring gene expression (general for lincRNAs, not specifically for LINC02372)
04
Disease associations
Other (no confirmed disease associations or roles for LINC02372 specifically reported in literature or databases as of this search)
05
Safety considerations
None reported (no clinical targeting or safety data)
06
Interacting drugs
None known (no drugs reported to target or interact with LINC02372)
07
Biomarkers
None known (no validation as a diagnostic, prognostic, or predictive biomarker for LINC02372)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2372 (LINC02372).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2372 (LINC02372).